Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Stoke Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of STOK: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1832198+17
Shares67.0M3.15M71.1M+7.28M (+11.4%)
Value$2.13B$100.0M$2.31B+$288.8M (+14.3%)

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (44)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to STOK in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC2,355,603$76.7M0.00%
Troluce Capital Advisors LLC652,800$21.3M2.25%
Millennium Management LLC472,141$15.4M0.01%
Vanguard Portfolio Management LLC462,682$15.1M0.00%
Vanguard Fiduciary Trust Co356,947$11.6M0.00%
Artisan Partners Limited Partnership315,492$10.3M0.02%
T. Rowe Price Investment Management, Inc.250,913$8.17M0.01%
EcoR1 Capital, LLC100,000$3.26M0.14%
TD Asset Management Inc74,400$2.42M0.00%
Boothbay Fund Management, LLC47,307$1.54M0.04%
Omers Administration Corp41,500$1.35M0.01%
Moran Wealth Management, LLC40,552$1.32M0.04%
Caption Management, LLC35,174$1.15M0.05%
Schroder Investment Management Group34,102$1.08M0.00%
Blackstone Group Inc.30,579$995.7K0.00%
Vanguard Global Advisers, LLC26,639$867.4K0.00%
Vanguard Asset Management, Ltd25,114$817.7K0.00%
HSBC Holdings PLC20,521$686.0K0.00%
Jefferies Financial Group Inc.16,300$530.7K0.01%
Universal- Beteiligungs- und Servicegesellschaft mbH16,206$527.7K0.00%
Cim, LLC14,228$463.3K0.07%
State of New Jersey Common Pension Fund D13,664$444.9K0.00%
Capstone Investment Advisors, LLC12,230$398.2K0.00%
Virtu Financial LLC11,042$360.0K0.01%
Harbor Capital Advisors, Inc.10,876$354.0K0.03%
Quadrature Capital Ltd10,293$335.1K0.00%
Vanguard Investments Australia, Ltd.10,186$331.7K0.00%
State Board of Administration of Florida Retirement System9,089$295.9K0.00%
Tema ETFs LLC8,540$278.1K0.02%
XTX Topco Ltd8,054$262.2K0.00%
Prudential Financial Inc7,640$248.8K0.00%
Pictet Asset Management Holding SA7,581$246.8K0.00%
E Fund Management Co., Ltd.7,530$245.2K0.01%
Caitong International Asset Management Co., Ltd5,662$184.4K0.03%
KBC Group NV1,096$36.0K0.00%
Kemnay Advisory Services Inc.471$15.3K0.00%
Owl Creek Wealth Partners LLC150$4.88K0.00%
LRI Investments, LLC146$4.75K0.00%
Financial Life Planners144$4.69K0.00%
Pension & Wealth Management Advisors, Inc.85$2.77K0.00%
MAI Capital Management3$980.00%
Twin Peaks Wealth Advisors, LLC3$980.00%
Keating Financial Advisory Services, Inc.1$330.00%
Covestor Ltd4$00.00%

Sold out (27)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (2)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STOK in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc3,149,239$100.0M
Global Retirement Partners, LLC35$1.11K